Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 30,000 shares at $19.13 ($578K) on 2026-03-23, disclosed to the SEC on 2026-03-25.
Scheduled sale ($578k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.13 | 10,000 | $191K | 33.1% |
| 2 | $19.13 | 10,000 | $191K | 33.1% |
| 3 | $19.52 | 5,000 | $98K | 16.9% |
| 4 | $19.52 | 5,000 | $98K | 16.9% |
| Total | $19.26 avg | 30,000 | $578K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |